Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

70.34
+0.71901.03%
Volume:9K
Turnover:630.54K
Market Cap:103.73M
PE:- -
High:70.61
Open:69.94
Low:69.80
Close:69.62
52wk High:71.10
52wk Low:40.17
Shares:1.47M
Float Shares:1.47M
Volume Ratio:1.31
T/O Rate:0.61%
Dividend:0.65
Dividend Rate:0.92%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Dow Jones
·
Sep 12

IntegraGen receives rival takeover bids amid court‑ordered restructuring

TIPRANKS
·
Sep 12

Moderna Inc Stock (MRNA) Moved Up by 8.63% on Sep 11: A Full Analysis

TradingKey
·
Sep 12

Moderately bullish activity in Moderna with shares up 8.03%

TIPRANKS
·
Sep 12

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 12

Berenberg Boosts Price Target on Moderna to $100 From $45, Keeps Hold Rating

MT Newswires Live
·
Sep 11

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

TIPRANKS
·
Sep 11

Analysts Offer Insights on NA Companies: Expeditors International (EXPD) and Illumina (ILMN)

TIPRANKS
·
Sep 11

Twist Bioscience Price Target Announced at $45.00/Share by BWS Financial

Dow Jones
·
Sep 10

Moderna Set for 3 Near-Term INT Data Readouts, UBS Says

MT Newswires Live
·
Sep 09

UBS Adjusts Guardant Health Price Target to $225 From $175, Maintains Buy Rating

MT Newswires Live
·
Sep 09

Twist Bioscience initiated with a Sell at BWS Financial

TIPRANKS
·
Sep 09

UBS Initiates Coverage on Twist Bioscience With Neutral Rating, $144 Price Target

MT Newswires Live
·
Sep 09

Twist Bioscience CEO, CFO to Speak at Baird Global Healthcare Conference Fireside Chat

Reuters
·
Sep 09

Structure weakness ‘disconnected’ from underlying data, says Jefferies

TIPRANKS
·
Sep 09

Moderately bullish activity in Moderna with shares down 1.79%

TIPRANKS
·
Sep 09

U.S. Stocks on the MOVE-Sigma Lithium, Shake Shack, Novartis

Reuters
·
Sep 08

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Guardant Health (GH) and Neurocrine (NBIX)

TIPRANKS
·
Sep 08

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

TIPRANKS
·
Sep 08

Guardant Health Price Target Announced at $203.00/Share by Rothschild & Co

Dow Jones
·
Sep 08